ACE2 and COVID-19: These data support a robust hypothesis that COVID-19 is an acquired molecular disease characterized by RAS dysregulation, namely, ACE2 downregulation, which leads to an exacerbated immune response, microcirculatory thrombosis, and fibrosis (18, 19).